
    
      This research study is a Phase II clinical trial. Phase II clinical trials test the safety
      and effectiveness of an investigational intervention to learn whether the intervention works
      in treating a specific disease. "Investigational" means that the intervention is being
      studied.

      The standard treatment for metastatic cholangiocarcinoma is combination chemotherapy with
      gemcitabine and cisplatin. The FDA (the U.S. Food and Drug Administration) has not approved
      dasatinib for your specific disease (Cholangiocarcinoma) but it has been approved for other
      uses (Chronic Myeloid Leukemia)
    
  